Innocoll patents expiration

1. Posimir patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11400019 INNOCOLL Sustained release drug delivery systems with reduced impurities and related methods
Jan, 2041

(17 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product (NP) Feb 1, 2024

Drugs and Companies using BUPIVACAINE ingredient

Market Authorisation Date: 01 February, 2021

Treatment: NA


More Information on Dosage

POSIMIR family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic